Department of Physiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Department of Forensic Pathology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Toxicol Lett. 2024 Apr;394:11-22. doi: 10.1016/j.toxlet.2024.02.002. Epub 2024 Feb 20.
The incidence of endocrine-related cancer, which includes tumors in major endocrine glands such as the breast, thyroid, pituitary, and prostate, has been increasing year by year. Various studies have indicated that brominated flame retardants (BFRs) are neurotoxic, endocrine-toxic, reproductive-toxic, and even carcinogenic. However, the epidemiological relationship between BFR exposure and endocrine-related cancer risk remains unclear.
We searched the PubMed, Google Scholar, and Web of Science databases for articles evaluating the association between BFR exposure and endocrine-related cancer risk. The odds ratio (OR) and its corresponding 95% confidence interval (95% CI) were used to assess the association. Statistical heterogeneity among studies was assessed with the Q-test and I statistics. Begg's test was performed to evaluate the publication bias.
We collected 15 studies, including 6 nested case-control and 9 case-control studies, with 3468 cases and 4187 controls. These studies assessed the risk of breast cancer, thyroid cancer, and endocrine-related cancers in relation to BFR levels. Our findings indicate a significant association between BFR exposure in adipose tissue and an increased risk of breast cancer. However, this association was not observed for thyroid cancer. Generally, BFR exposure appears to elevate the risk of endocrine-related cancers, with a notable increase in risk linked to higher levels of BDE-28, a specific polybrominated diphenyl ether congener.
In conclusion, although this meta-analysis has several limitations, our results suggest that BFR exposure is a significant risk factor for breast cancer, and low-brominated BDE-28 exposure could significantly increase the risk of endocrine-related cancers. Further research is essential to clarify the potential causal relationships between BFRs and endocrine-related cancers, and their carcinogenic mechanisms.
内分泌相关癌症(包括乳腺、甲状腺、垂体和前列腺等主要内分泌腺的肿瘤)的发病率逐年上升。多项研究表明,溴系阻燃剂(BFRs)具有神经毒性、内分泌毒性、生殖毒性,甚至致癌性。然而,BFR 暴露与内分泌相关癌症风险之间的流行病学关系尚不清楚。
我们检索了 PubMed、Google Scholar 和 Web of Science 数据库中评估 BFR 暴露与内分泌相关癌症风险之间关联的文章。使用比值比(OR)及其对应的 95%置信区间(95%CI)来评估相关性。使用 Q 检验和 I 统计量评估研究之间的统计学异质性。使用 Begg 检验评估发表偏倚。
我们收集了 15 项研究,包括 6 项巢式病例对照研究和 9 项病例对照研究,共纳入 3468 例病例和 4187 例对照。这些研究评估了 BFR 水平与乳腺癌、甲状腺癌和内分泌相关癌症风险之间的关系。我们的研究结果表明,脂肪组织中的 BFR 暴露与乳腺癌风险增加之间存在显著关联。然而,这种关联在甲状腺癌中并未观察到。一般来说,BFR 暴露似乎会增加内分泌相关癌症的风险,而特定的多溴二苯醚同系物 BDE-28 水平升高与风险增加显著相关。
尽管本荟萃分析存在一些局限性,但我们的结果表明,BFR 暴露是乳腺癌的一个重要危险因素,低溴化 BDE-28 暴露可能显著增加内分泌相关癌症的风险。需要进一步的研究来阐明 BFR 与内分泌相关癌症之间的潜在因果关系及其致癌机制。